JW Therapeutics (čÆęå·ØčÆŗ) IPO Trading: Peer Performance Doesn't Support a Strong Debut
In this note, we will look at the allocation and implications. We think the IPO valuation is reasonable with long term upsides given its leadership...
689 Views
JW Therapeutics - Concerns Are in the Short Term but Still Promising in the Long Term
This article analyzed the concerns (market size, high cost, financial performance, etc.) for JW Therapeutics in the short run but also include...
577 Views
Li Auto (ēę³ę±½č½¦) Trading Update - No Mention of Hillhouse's Investment
Li Auto Inc. (LI US) raised about US$1.1bn at US$11.50 per share, above the top-end of its IPO price range last night. We have covered the deal in...
717 Views
Immunotech Biopharm (ę°øę³°ēē©) IPO: Behind the Curve in Cell Therapy
Immunotech Biopharma, a cell therapy focused healthcare company, launched book building to raise up to USD 142 million to list in Hong Kong. In our...
845 Views
ECM Weekly (7 June 2020) - JD & NetEase HK Bookbuild, Burning Rock & Nongfu Spring Valuation
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...
591 Views